A UK-based global biopharmaceutical company that researches, develops and markets prescription medicines and vaccines across areas including respiratory, HIV, oncology and immunology.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 76 | New buy | 2,661,281 | $139,504,350 | 0.2% |
| Bridgewater | 56 | Trimmed -28% | 504,171 | $26,428,644 | 0.1% |
| Ancora | 40 | Trimmed -74% | 1,362 | $71,396 | 0.0% |
| Paul Tudor Jones / Tudor | 63 | Trimmed -92% | 4,000 | $209,680 | 0.0% |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.